Spinal Cord Injury
Researchers at UC San Diego are collaborating with Neuralstem, Inc. to conduct the safety trial of neural stem cell transplantation in paralysis patients due to traumatic injury within spinal cord segments T2-T12.
The transplantation involves the injection of nueral stem cells into the spinal cord. This first in human clinical trial evaluates the safety of transplanting neural stem cells into the spine.
More Information
To learn about eligibility for this clinical trial, please call the Alpha Stem Cell Clinic (844) 317-STEM (7836) or e-mail
alphastemcellclinic@ucsd.edu.
Chronic Lymphocytic Leukemia
Researchers at UC San Diego are conducting the Phase 1 clinical trial of the intravenous infusion of an antibody that targets cancer stem cells in people with relapsed or refractory chronic lymphocytic leukemia (CLL).
This antibody, developed at UC San Diego, is designed to attach to a protein, called ROR1, on the surface of CLL cells to block cell growth and survival. This first in human trial evaluates whether the intravenous infusion is safe and well-tolerated.
More Information
To learn about eligibility for this clinical trial, please call Jesika Reiner at (858) 822-5364 or e-mail
jreiner@ucsd.edu.